Clinical Trials Sponsored by ECRI bv

Total 547 results

SMART Clinical Products BV
Ziekenhuis Oost-Limburg

Completed

Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. (iD-System)

Ventricular Fibrillation | Ventricular Tachycardia

Belgium
Enceladus Pharmaceuticals BV
University Hospital, Aachen; Accelovance

Terminated

A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma (AMETHYST)

Multiple Myeloma
Wageningen University and Research
Asahimatsu Support BV

Completed

Kori-tofu Proteins and Blood Glucose Response (KoPro)

Glucose Intolerance

Netherlands
Acerta Pharma BV
Merck Sharp & Dohme LLC

Completed

Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer (KEYNOTE166)

Carcinoma, Non-Small-Cell Lung

United States
Janssen Research & Development, LLC
Janssen Biologics BV

Completed

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Ulcerative Colitis

United States, France, United Kingdom, Belgium, Switzerland, Israel, Canada, Australia, Netherlands, New Zealand, Austria, Germany, Denmark, Czechia, Argentina
Sahajanand Medical Technologies Pvt. Ltd.
Cardialysis BV

Terminated

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Coronary Artery Disease

India, Brazil, Saudi Arabia
Maastricht University Medical Center
Biomet Nederland BV

Unknown

Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter?

Rectal Fistula

Netherlands
Khondrion BV
Julius Clinical; ProPharma Group; Certara

Completed

The KHENEREXT Study

Mitochondrial Diseases | Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation | Maternally Inherited Diabetes and Deafness (MIDD) | Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke Like Episodes (MELAS) | Chronic Progressive External Ophthalmoplegia (CPEO)

Netherlands, Denmark, United Kingdom, Germany
Atlantia Food Clinical Trials
Caelus Pharmaceuticals BV

Completed

Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic Control

Glucose Metabolism Disorders | Metabolic Syndrome | Insulin Resistance | Impaired Glucose Tolerance | Insulin Sensitivity | Pre Diabetes

Ireland, United States, United Kingdom
Acerta Pharma BV
Merck Sharp & Dohme LLC

Completed

Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma (KEYNOTE147)

Squamous Cell Carcinoma of the Head and Neck

United States
Acerta Pharma BV
Merck Sharp & Dohme LLC

Completed

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer (KEYNOTE143)

Metastatic Urothelial Carcinoma

United States
University of Pittsburgh
MucoVax, BV, the Netherlands

Terminated

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Positive C-Diff Culture

United States
KCRI
SIS Medical AG

Completed

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Angina, Stable | Angina, Unstable

Switzerland
Eclipse Medical Ltd.
KCRI

Recruiting

Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk (Omega)

Non-Valvular Atrial Fibrillation

Denmark, Germany, Italy, Spain, United Kingdom
SCRI Development Innovations, LLC

Withdrawn

iCORE: Collaborative Orthopedics Outcomes Registry (iCORE)

Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip

United States
SCRI Development Innovations, LLC

Withdrawn

Sarah Cannon Outcomes Registry

Oncology

United States
SCRI Development Innovations, LLC

Terminated

SCRI Tissue Testing Registry

Melanoma | Lymphoma | Multiple Myeloma | Myelodysplastic Syndrome

United States
KCRI
Vascular Concepts Limited

Completed

A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System (EURONOVA)

Myocardial Ischemia

Poland
SCRI Development Innovations, LLC

Terminated

A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

United States
Eximo Medical Ltd.
KCRI

Completed

Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment

Peripheral Arterial Disease

Poland
SCRI Development Innovations, LLC

Completed

Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

Metastatic Breast Cancer

United States
Vissum, Instituto Oftalmológico de Alicante
AkkoLens Clinical bv

Completed

Efficacy of the AkkoLens IOL in Patients With Cataract

Cataract
Cardiovascular Research Foundation, New York
Cardialysis BV; Avania

Active, not recruiting

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Aortic Valve Stenosis

United States, Canada, Netherlands
Maastricht University Medical Center
Winclove Bio Industries BV

Completed

The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients

Hypersensitivity | Irritable Bowel Syndrome

Netherlands
Maastricht University Medical Center
Stryker European Operations BV

Completed

RCT Comparing the DEXA Results of the HA-Omnifit Versus the Symax Uncemented Hip Stem

Patients With Osteoarthritis of the Hip Joint Elligable for a Uncemented Hipprosthesis
University Medical Center Groningen
Netherlands Heart Foundation; Disphar International B.V.; Teva Nederland BV; Tiofarma... and other collaborators

Active, not recruiting

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands (DECISION)

Heart Failure

Netherlands
LiteVax BV
University Hospital, Ghent; HarmonyCR, Melle, Belgium

Recruiting

Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine (TETRALITE-Ib)

Vaccination Reaction

Belgium
Fondazione Policlinico Universitario Agostino Gemelli...
Onera BV

Recruiting

Ultrasound and Respiratory Physiological Signals in Lung Diseases (SAURON)

Chronic Obstructive Pulmonary Disease | Ultrasonography | Interstitial Lung Disease | Ultrasound | Emphysema or COPD | Ultrasound Imaging | Interstitial Lung Diseases | Interstitial Pneumonia

Italy
Acerta Pharma BV
National Institutes of Health (NIH)

Active, not recruiting

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Washington University School of Medicine
Acerta Pharma BV

Active, not recruiting

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
GSO Global Clinical Research BV
Karyopharm Therapeutics Inc

Terminated

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer (SENTINEL)

Colorectal Neoplasm

Germany, Belgium
GSO Global Clinical Research BV
Karyopharm Therapeutics Inc

Completed

A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (Relapsed/Refractory)

Germany
Newtricious R&D BV
Sprim Advanced Life Sciences

Completed

Intervention Trial in Early Age-related Macular Degeneration (I-TEAM)

Age-related Macular Degeneration (AMD)

United States, Germany, Netherlands, United Kingdom
Abbott
Quintiles, Inc.; Synexus; author! et al. BV

Completed

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Essential Hypertension

Germany, Russian Federation, United Kingdom
Maastricht University Medical Center
Stryker European Operations BV

Unknown

RSA Study Using Two Types of Uncemented Acetabular Components and the Uncemented HA Coated Symax Stem (RSA)

Osteoarthritis

Netherlands
Martini Hospital Groningen
Baxter Healthcare Corporation; Roche BV Netherlands

Terminated

Peritoneal Dialysis in Congestive Heart Failure (PDinCHF)

Congestive Heart Failure

Netherlands
SCRI Development Innovations, LLC
Pfizer

Withdrawn

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib (NSCLC)

Lung Cancer | Non-small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Ipsen

Terminated

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Gastrointestinal Neoplasms | Neuroendocrine Tumors | Carcinoid Tumors

United States
SCRI Development Innovations, LLC
Celgene

Completed

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Gastroesophageal Cancer

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Terminated

Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma

United States
AstraZeneca
SCRI Development Innovations, LLC

Completed

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Papillary Renal Cell Cancer

United States, Canada, United Kingdom, Spain
SCRI Development Innovations, LLC
Novartis

Completed

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Sanofi

Completed

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

Rectal Cancer

United States
SCRI Development Innovations, LLC
Pfizer

Completed

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Terminated

Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer

HER2 Positive Esophagogastric Cancer

United States
SCRI Development Innovations, LLC
Celgene

Completed

A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer

Extensive-Stage Small Cell Lung Cancer

United States
Seattle Children's Research Institute (SCRI)

Completed

Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes

Malaria

United States
SCRI Development Innovations, LLC
Amgen

Completed

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

Infusion Reaction

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Fundacja Ośrodek Badań Medycznych
KCRI

Withdrawn

Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment. (REL-0609)

Acute Myocardial Infarction

Poland

Clinical Trials Sponsored by ECRI bv

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations